IBB:NASDAQiShares Biotechnology ETF analysis
Data as of Oct 8, 2026 - not real-time
- Latest price
- $197.60
- Risk: low
- 2/10Low risk
Summary
iShares Biotechnology ETF trades at $197.60, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Across the trailing 30 sessions it lost 8.2%. With RSI at 37.3 the momentum picture is approaching oversold, alongside a bearish MACD signal. Watch $197.16 as support and $212.62 as the nearer resistance level.
The 0.44% expense ratio is competitive for its category, and the fund manages $11.20B in assets.
On a 1-10 scale the risk profile lands at 2 — low. With 30-day volatility of 22.1%, a beta of 0.77 and a maximum drawdown of 9.7%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 3 out of 10.
The 0.44% expense ratio is competitive for its category, and the fund manages $11.20B in assets.
On a 1-10 scale the risk profile lands at 2 — low. With 30-day volatility of 22.1%, a beta of 0.77 and a maximum drawdown of 9.7%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 3 out of 10.
Top market events
- VHT offers broad sector exposure, while IBB concentrates on biotech with higher growth but steeper drawdowns.
- Yahoo Finance1monIs iShares Biotechnology ETF IBB a Strong ETF Right Now?
- Morningstar%2c Inc.2moniShares Biotechnology ETF IBB StrategyThe investment seeks to track the investment results of...
Market outlook
Short term
< 1 yearPositive
Model confidence5/105 out of 10
Key factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 181.75
- MACD momentum is negative
Medium term
1–3 yearsNeutral
Model confidence4/104 out of 10
Key factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 181.75
- MACD momentum is negative
Long term
> 3 yearsNeutral
Model confidence3/103 out of 10
Key factors
- Short-term moving averages stacked above long-term ones
- 30-day volatility of 22.1%
- Beta of 0.77 versus the benchmark
Key metrics
Fund metrics
Expense Ratio0.44%
AUM$11.2B
Inception Date2001-02-05
Avg Daily Volume1,635,060
Premium/Discount0.00%
Tracking Error0.00%
Dividend Yield0.16%
Technical analysis
TrendBullish
RSI37.3
Support$197.16
Resistance$212.62
MA 20$206.13
MA 50$204.90
MA 200$181.75
MACDBearish
VolumeStable
Fear & Greed Index93.68
Risk assessment
Beta0.77
Volatility22.13%
Sector RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.